Business Insider

Recce Pharmaceuticals Announces Appointment of Global Infectious Disease Expert Professor Philip Sutton to H. Pylori Development Program

SYDNEY, Australia, Aug. 24, 2020 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE) (Company), the Company developing new classes of synthetic anti-infectives, today announced the appointment of ...
Business Insider

Recce Pharmaceuticals Completes Stage 1 Data Analysis of Phase I/II Clinical Trial for the Treatment of Burn Wound Infections

Patients with bacterial infections successfully treated with RECCE ® 327 (R327) Deadly bacterial pathogens treated with R327 include those identified by the World Health Organization as major threats ...